RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36 | -16.3% | 33,727 | +1.6% | 0.00% | – |
| Q2 2023 | $43 | -2.3% | 33,193 | -0.7% | 0.00% | – |
| Q1 2023 | $44 | -71.1% | 33,441 | -67.1% | 0.00% | – |
| Q4 2022 | $152 | -99.9% | 101,541 | +0.1% | 0.00% | – |
| Q3 2022 | $120,000 | +5.3% | 101,464 | +0.3% | 0.00% | – |
| Q2 2022 | $114,000 | -62.5% | 101,195 | -0.3% | 0.00% | – |
| Q1 2022 | $304,000 | +13.0% | 101,531 | +0.1% | 0.00% | – |
| Q4 2021 | $269,000 | -27.1% | 101,449 | -0.3% | 0.00% | – |
| Q3 2021 | $369,000 | -33.4% | 101,787 | -20.2% | 0.00% | -100.0% |
| Q2 2021 | $554,000 | +8.4% | 127,540 | -14.6% | 0.00% | 0.0% |
| Q1 2021 | $511,000 | -2.3% | 149,400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $523,000 | +45.7% | 149,400 | 0.0% | 0.00% | – |
| Q3 2020 | $359,000 | +31.5% | 149,400 | 0.0% | 0.00% | – |
| Q2 2020 | $273,000 | +17.2% | 149,400 | 0.0% | 0.00% | – |
| Q1 2020 | $233,000 | -27.2% | 149,400 | 0.0% | 0.00% | – |
| Q4 2019 | $320,000 | +14.7% | 149,400 | 0.0% | 0.00% | – |
| Q3 2019 | $279,000 | -28.5% | 149,400 | 0.0% | 0.00% | – |
| Q2 2019 | $390,000 | +1.6% | 149,400 | 0.0% | 0.00% | – |
| Q1 2019 | $384,000 | +11.6% | 149,400 | 0.0% | 0.00% | – |
| Q4 2018 | $344,000 | -28.9% | 149,400 | -1.0% | 0.00% | -100.0% |
| Q3 2018 | $484,000 | +13.3% | 150,900 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $427,000 | -17.9% | 150,900 | +2.7% | 0.00% | 0.0% |
| Q1 2018 | $520,000 | +16.1% | 147,000 | +27.4% | 0.00% | 0.0% |
| Q4 2017 | $448,000 | +52.9% | 115,400 | 0.0% | 0.00% | – |
| Q3 2017 | $293,000 | -7.0% | 115,400 | 0.0% | 0.00% | – |
| Q2 2017 | $315,000 | -34.1% | 115,400 | -20.1% | 0.00% | -100.0% |
| Q1 2017 | $478,000 | +83.1% | 144,401 | +31.9% | 0.00% | – |
| Q4 2016 | $261,000 | -35.1% | 109,500 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $402,000 | +64.8% | 109,500 | 0.0% | 0.00% | – |
| Q2 2016 | $244,000 | +7.0% | 109,500 | 0.0% | 0.00% | – |
| Q1 2016 | $228,000 | -31.3% | 109,500 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $332,000 | +23.0% | 109,500 | 0.0% | 0.00% | – |
| Q3 2015 | $270,000 | -30.6% | 109,500 | -9.6% | 0.00% | -100.0% |
| Q2 2015 | $389,000 | +274.0% | 121,093 | +317.6% | 0.00% | – |
| Q1 2015 | $104,000 | – | 29,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |